title: Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration.
authors.forename: M D
authors.initials: MD
authors.lastname: Edstein
authors.forename: B M
authors.initials: BM
authors.lastname: Kotecka
authors.forename: K L
authors.initials: KL
authors.lastname: Anderson
authors.forename: D J
authors.initials: DJ
authors.lastname: Pombo
authors.forename: D E
authors.initials: DE
authors.lastname: Kyle
authors.forename: K H
authors.initials: KH
authors.lastname: Rieckmann
authors.forename: M F
authors.initials: MF
authors.lastname: Good
mesh_terms: D000818:Animals; D000962:Antimalarials / Q000008:administration & dosage* / Q000097:blood* / Q000493:pharmacokinetics / Q000494:pharmacology; D053626:Atovaquone; D001681:Biological Assay; D002851:Chromatography, High Pressure Liquid; D004359:Drug Therapy, Combination; D006207:Half-Life; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy; D009285:Naphthoquinones / Q000008:administration & dosage* / Q000097:blood* / Q000493:pharmacokinetics / Q000494:pharmacology; D010963:Plasmodium falciparum / Q000187:drug effects / Q000235:genetics; D002727:Proguanil / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000494:pharmacology
chemical_list: D000962:Antimalarials; D009285:Naphthoquinones; D002727:Proguanil; D053626:Atovaquone